HJ Research delivers in-depth insights on the global Transcriptomics market in its upcoming report titled, Global Transcriptomics Market Report 2018-2029. According to this study, the global Transcriptomics market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Transcriptomics market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Transcriptomics market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Transcriptomics industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Transcriptomics industry.
Global Transcriptomics market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Transcriptomics industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Transcriptomics market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Transcriptomics. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Transcriptomics market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Transcriptomics in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Transcriptomics market include:
QIAGEN (Exiqon)
Thermo Fisher Scientific
Illumina
Agilent Technologies
GE Healthcare Dharmacon
Bio-Rad Laboratories
F. Hoffmann-La Roche
Merck
Fluidigm Corporation
Promega Corporation
Market segmentation, by product types:
Real Time-PCR (qPCR)
Microarray
Sequencing
Market segmentation, by applications:
Government Institutes & Academic Centers
Pharmaceutical & Biotechnology Companies
Contract research Organizations (CROs)
1 Industry Overview of Transcriptomics
1.1 Research Scope
1.2 Market Segmentation by Types of Transcriptomics
1.3 Market Segmentation by End Users of Transcriptomics
1.4 Market Dynamics Analysis of Transcriptomics
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Transcriptomics Industry
2.1 QIAGEN (Exiqon)
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Thermo Fisher Scientific
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Illumina
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Agilent Technologies
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 GE Healthcare Dharmacon
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Bio-Rad Laboratories
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 F. Hoffmann-La Roche
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Merck
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Fluidigm Corporation
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Promega Corporation
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Transcriptomics Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
3 Global Transcriptomics Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Transcriptomics by Regions (2018-2023)
3.2 Global Sales Revenue of Transcriptomics by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Transcriptomics by Types (2018-2023)
3.4 Global Sales Revenue of Transcriptomics by End Users (2018-2023)
4 Northern America Transcriptomics Market Analysis by Countries, Types and End Users
4.1 Northern America Transcriptomics Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Transcriptomics Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Transcriptomics Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Transcriptomics Sales Revenue Analysis (2018-2023)
4.5 Canada Transcriptomics Sales Revenue Analysis (2018-2023)
5 Europe Transcriptomics Market Analysis by Countries, Types and End Users
5.1 Europe Transcriptomics Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Transcriptomics Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Transcriptomics Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Transcriptomics Sales Revenue Analysis (2018-2023)
5.5 France Transcriptomics Sales Revenue Analysis (2018-2023)
5.6 UK Transcriptomics Sales Revenue Analysis (2018-2023)
5.7 Italy Transcriptomics Sales Revenue Analysis (2018-2023)
5.8 Russia Transcriptomics Sales Revenue Analysis (2018-2023)
5.9 Spain Transcriptomics Sales Revenue Analysis (2018-2023)
5.10 Netherlands Transcriptomics Sales Revenue Analysis (2018-2023)
6 Asia Pacific Transcriptomics Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Transcriptomics Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Transcriptomics Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Transcriptomics Sales Revenue Analysis by End Users (2018-2023)
6.4 China Transcriptomics Sales Revenue Analysis (2018-2023)
6.5 Japan Transcriptomics Sales Revenue Analysis (2018-2023)
6.6 Korea Transcriptomics Sales Revenue Analysis (2018-2023)
6.7 India Transcriptomics Sales Revenue Analysis (2018-2023)
6.8 Australia Transcriptomics Sales Revenue Analysis (2018-2023)
6.9 Indonesia Transcriptomics Sales Revenue Analysis (2018-2023)
6.10 Vietnam Transcriptomics Sales Revenue Analysis (2018-2023)
7 Latin America Transcriptomics Market Analysis by Countries, Types and End Users
7.1 Latin America Transcriptomics Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Transcriptomics Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Transcriptomics Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Transcriptomics Sales Revenue Analysis (2018-2023)
7.5 Mexico Transcriptomics Sales Revenue Analysis (2018-2023)
7.6 Argentina Transcriptomics Sales Revenue Analysis (2018-2023)
7.7 Colombia Transcriptomics Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Transcriptomics Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Transcriptomics Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Transcriptomics Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Transcriptomics Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Transcriptomics Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Transcriptomics Sales Revenue Analysis (2018-2023)
8.6 South Africa Transcriptomics Sales Revenue Analysis (2018-2023)
8.7 Egypt Transcriptomics Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Transcriptomics Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Transcriptomics by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Transcriptomics by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Transcriptomics by End Users (2024-2029)
10.4 Global Revenue Forecast of Transcriptomics by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Transcriptomics
11.1 Upstream Analysis of Transcriptomics
11.2 Downstream Major Consumers Analysis of Transcriptomics
11.3 Major Suppliers of Transcriptomics with Contact Information
11.4 Supply Chain Relationship Analysis of Transcriptomics
12 Transcriptomics New Project Investment Feasibility Analysis
12.1 Transcriptomics New Project SWOT Analysis
12.2 Transcriptomics New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Transcriptomics Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Transcriptomics
Table End Users of Transcriptomics
Figure Market Drivers Analysis of Transcriptomics
Figure Market Challenges Analysis of Transcriptomics
Figure Market Opportunities Analysis of Transcriptomics
Table Market Drivers Analysis of Transcriptomics
Table QIAGEN (Exiqon) Information List
Figure Transcriptomics Specifications of QIAGEN (Exiqon)
Table Transcriptomics Revenue (Million USD) and Gross Margin of QIAGEN (Exiqon) (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of QIAGEN (Exiqon) (2018-2023)
Table Thermo Fisher Scientific Information List
Figure Transcriptomics Specifications of Thermo Fisher Scientific
Table Transcriptomics Revenue (Million USD) and Gross Margin of Thermo Fisher Scientific (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of Thermo Fisher Scientific (2018-2023)
Table Illumina Information List
Figure Transcriptomics Specifications of Illumina
Table Transcriptomics Revenue (Million USD) and Gross Margin of Illumina (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of Illumina (2018-2023)
Table Agilent Technologies Information List
Figure Transcriptomics Specifications of Agilent Technologies
Table Transcriptomics Revenue (Million USD) and Gross Margin of Agilent Technologies (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of Agilent Technologies (2018-2023)
Table GE Healthcare Dharmacon Information List
Figure Transcriptomics Specifications of GE Healthcare Dharmacon
Table Transcriptomics Revenue (Million USD) and Gross Margin of GE Healthcare Dharmacon (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of GE Healthcare Dharmacon (2018-2023)
Table Bio-Rad Laboratories Information List
Figure Transcriptomics Specifications of Bio-Rad Laboratories
Table Transcriptomics Revenue (Million USD) and Gross Margin of Bio-Rad Laboratories (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of Bio-Rad Laboratories (2018-2023)
Table F. Hoffmann-La Roche Information List
Figure Transcriptomics Specifications of F. Hoffmann-La Roche
Table Transcriptomics Revenue (Million USD) and Gross Margin of F. Hoffmann-La Roche (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of F. Hoffmann-La Roche (2018-2023)
Table Merck Information List
Figure Transcriptomics Specifications of Merck
Table Transcriptomics Revenue (Million USD) and Gross Margin of Merck (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of Merck (2018-2023)
Table Fluidigm Corporation Information List
Figure Transcriptomics Specifications of Fluidigm Corporation
Table Transcriptomics Revenue (Million USD) and Gross Margin of Fluidigm Corporation (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of Fluidigm Corporation (2018-2023)
Table Promega Corporation Information List
Figure Transcriptomics Specifications of Promega Corporation
Table Transcriptomics Revenue (Million USD) and Gross Margin of Promega Corporation (2018-2023)
Figure Transcriptomics Revenue (Million USD) and Global Market Share of Promega Corporation (2018-2023)
Table Global Revenue (Million USD) of Transcriptomics by Regions (2018-2023)
Table Global Revenue (Million USD) of Transcriptomics by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Transcriptomics by Types (2018-2023)
Table Global Revenue (Million USD) of Transcriptomics by End Users (2018-2023)
Table Northern America Transcriptomics Revenue (Million USD) by Countries (2018-2023)
Table Northern America Transcriptomics Revenue (Million USD) by Types (2018-2023)
Table Northern America Transcriptomics Revenue (Million USD) by End Users (2018-2023)
Figure United States Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Transcriptomics Revenue (Million USD) by Countries (2018-2023)
Table Europe Transcriptomics Revenue (Million USD) by Types (2018-2023)
Table Europe Transcriptomics Revenue (Million USD) by End Users (2018-2023)
Figure Germany Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Transcriptomics Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Transcriptomics Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Transcriptomics Revenue (Million USD) by End Users (2018-2023)
Figure China Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Transcriptomics Revenue (Million USD) by Countries (2018-2023)
Table Latin America Transcriptomics Revenue (Million USD) by Types (2018-2023)
Table Latin America Transcriptomics Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Transcriptomics Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Transcriptomics Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Transcriptomics Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Transcriptomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Transcriptomics by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Transcriptomics by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Transcriptomics by End Users (2024-2029)
Table Major Consumers with Contact Information of Transcriptomics
Table Major Suppliers of Transcriptomics with Contact Information
Figure Supply Chain Relationship Analysis of Transcriptomics
Table New Project SWOT Analysis of Transcriptomics
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Transcriptomics
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Transcriptomics Industry
Table Part of References List of Transcriptomics Industry
Table Units of Measurement List
Table Part of Author Details List of Transcriptomics Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Transcriptomics industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Transcriptomics market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Transcriptomics manufacturers, Transcriptomics raw material suppliers, Transcriptomics distributors as well as buyers. The primary sources from the supply side include Transcriptomics manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Transcriptomics raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Transcriptomics industry landscape and trends, Transcriptomics market dynamics and key issues, Transcriptomics technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Transcriptomics competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Transcriptomics market size and forecast by regions, Transcriptomics market size and forecast by application, Transcriptomics market size and forecast by types, Transcriptomics company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
